Astrocytoma risk factors

Jump to navigation Jump to search

Astrocytoma Microchapters


Patient Information


Historical Perspective




Differentiating Astrocytoma from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings



Echocardiography and Ultrasound



Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Study

Case #1

Astrocytoma risk factors On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Astrocytoma risk factors

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Astrocytoma risk factors

CDC on Astrocytoma risk factors

Astrocytoma risk factors in the news

Blogs on Astrocytoma risk factors

Directions to Hospitals Treating Astrocytoma

Risk calculators and risk factors for Astrocytoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.


Common risk factors in the development of astrocytoma include environmental factors such as vinyl chloride, phenols, organic solvents, pesticides, formaldehyde, lubricating fluids, polycyclic aromatic hydrocarbons, and past radiation therapy to the brain and genetic diseases such as neurofibromatosis, tuberous sclerosis, Li-Fraumeni syndrome, nevoid basal cell carcinoma syndrome, Turcot syndrome and melanoma-astrocytoma syndrome. Less common risk factors include blood group A, previous head trauma, history of meningitis, history of epilepsy.

Risk Factors

Common Risk Factors

Less Common Risk Factors


  1. Caporalini C, Buccoliero AM, Scoccianti S, Moscardi S, Simoni A, Pansini L, Bordi L, Ammannati F, Taddei GL (2016). "Granular cell astrocytoma: report of a case and review of the literature". Clin. Neuropathol. 35 (4): 186–93. doi:10.5414/NP300952. PMID 27125869.
  2. Sheppard JP, Nguyen T, Alkhalid Y, Beckett JS, Salamon N, Yang I (April 2018). "Risk of Brain Tumor Induction from Pediatric Head CT Procedures: A Systematic Literature Review". Brain Tumor Res Treat. 6 (1): 1–7. doi:10.14791/btrt.2018.6.e4. PMC 5932294. PMID 29717567.
  3. Soura E, Eliades PJ, Shannon K, Stratigos AJ, Tsao H (March 2016). "Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome". J. Am. Acad. Dermatol. 74 (3): 395–407, quiz 408–10. doi:10.1016/j.jaad.2015.08.038. PMC 4761105. PMID 26892650.
  4. Chourmouzi D, Papadopoulou E, Konstantinidis M, Syrris V, Kouskouras K, Haritanti A, Karkavelas G, Drevelegas A (June 2014). "Manifestations of pilocytic astrocytoma: a pictorial review". Insights Imaging. 5 (3): 387–402. doi:10.1007/s13244-014-0328-2. PMC 4035491. PMID 24789122.
  5. Gajavelli S, Nakhla J, Nasser R, Yassari R, Weidenheim KM, Graber J (2016). "Ollier disease with anaplastic astrocytoma: A review of the literature and a unique case". Surg Neurol Int. 7 (Suppl 23): S607–11. doi:10.4103/2152-7806.189731. PMC 5025950. PMID 27656320.
  6. BUCKWALTER JA, TURNER JH, GAMBER HH, RATERMAN L, SOPER RT, KNOWLER LA (April 1959). "Psychoses, intracranial neoplasms, and genetics". AMA Arch Neurol Psychiatry. 81 (4): 480–5. PMID 13636517.
  7. 7.0 7.1 Schlehofer B, Blettner M, Becker N, Martinsohn C, Wahrendorf J (May 1992). "Medical risk factors and the development of brain tumors". Cancer. 69 (10): 2541–7. PMID 1568177.
  8. Hochberg F, Toniolo P, Cole P (November 1984). "Head trauma and seizures as risk factors of glioblastoma". Neurology. 34 (11): 1511–4. PMID 6493505.

Template:WH Template:WS